相关实验视频
Updated: May 5, 2026

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.3K
2型糖尿病的病理生理学和治疗:对过去,现在和未来的观点
Steven E Kahn1, Mark E Cooper2, Stefano Del Prato3
1Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System, University of Washington, Seattle, WA, USA.
Lancet (London, England)
|December 10, 2013
概括
了解葡萄糖代谢是管理2型糖尿病的关键. 研究突出了环境因素和微生物群.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 正常的葡萄糖代谢依赖于小岛贝塔细胞和胰岛素敏感性.
- 胰岛素抵抗可以通过增加β细胞输出来补偿,但最终会导致高血糖症.
- 贝塔细胞功能障碍涉及遗传和环境因素,包括饮食和微生物群.
研究的目的:
- 审查目前对葡萄糖代谢调节和功能障碍的理解.
- 探索环境因素和微生物组在胰岛素抵抗和β细胞功能障碍中的作用.
- 讨论2型糖尿病的当前和必要的治疗策略.
主要方法:
- 对现代研究方法的审查.
- 对临床试验结果的分析.
- 检查影响胰岛素抵抗和β细胞功能的因素.
主要成果:
- 六合体,氨基酸,脂肪酸和微生物组的变化显著影响胰岛素抵抗和β细胞功能障碍.
- 目前的治疗方法有前途,但需要更有效的疗法来减缓β细胞损失.
- 临床试验为预防和治疗提供了洞察力,但长期研究至关重要.
结论:
- 有效管理2型糖尿病需要解决环境因素和β细胞功能.
- 进一步的研究和长期研究对于开发新疗法和预防策略至关重要.
- 减缓渐进的β细胞损失是改善2型糖尿病结果的关键目标.
相关概念视频
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75

